| Date | Title | | | 06/05/13 | Bacterin International Announces Financing| BELGRADE, Mont.--(BUSINESS WIRE)--Jun. 5, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it has entered into a
definitive securities purchase agreement with both existing and new
investors to purchase 8.51 million unregistered shares of its common
stock and warrants to purchase approximately 4.25 million shares of i... |
|  | | 05/16/13 | Bacterin Receives Compliance Notice from NYSE MKT| BELGRADE, Mont.--(BUSINESS WIRE)--May. 16, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it has received a compliance
notice from the NYSE MKT compliance group.
Specifically the notice indicated that the Company is not in compliance
with Sections 1003(a)(iii) and 1003(a)(ii), regarding stockholder’s
... |
| | | 05/09/13 | Bacterin Announces First Quarter 2013 Revenue of $8.6 Million| First Quarter 2013 Highlights:
Revenue increased 11% year over year, to approximately $8.6 million,
and increased 6% over reported revenues for the fourth quarter of 2012
Loss from operations decreased 3% compared to the first quarter of
2012, to approximately $(1.2) million, and decreased 65% compared to
the loss from operations in the fourth quarter of 2012
BELGRADE, Mont.--(BUSINESS WIRE)--... |
| | | 04/30/13 | Bacterin Announces Earnings Release and Conference Call Date for 2013 First Quarter Results| BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 30, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it will release its financial
results for the period ended March 31, 2013, on May 9, 2013 at the close
of the financial markets.
An accompanying conference call hosted by John Gandolfo, Chief Financial
Officer an... |
| | | 04/26/13 | Bacterin Announces Selection of Executive Search Firm| BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 26, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced the selection of O’Hara
Associates, Inc. of Deerfield, Illinois to assist in the recruitment of
a Chief Executive Officer.
The recommendation to retain the firm was made by the Board’s
Nominations and Corporate Govern... |
| | | 04/17/13 | Bacterin Announces Updates on Executive Leadership Transition Plans| Company in final stages of identifying search firm; several candidates express interest
BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 17, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it is in the final stages of identifying a key executive search firm to assist with the identification of a new Chief Executive Officer. The Company has narrowed its selection to ... |
| | | 04/01/13 | Bacterin Announces Transition of Executive Leadership| Company has begun process to identify candidates for Chief Executive Officer
BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 1, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced it will begin the process of identifying a successor to the Company’s Chief Executive Officer and President, Guy Cook. Mr. Cook will remain Chief Executive Officer and President until a successor ... |
| | | 03/26/13 | Bacterin Announces Record 2012 Revenue of $33 Million| Full Year 2012 Highlights:
Revenue increased 9% to approximately $33.0 million in 2012, compared
to approximately $30.1 million for fiscal year 2011
Loss from operations improved by 23% to approximately $(4.9) million,
compared to approximately $(6.5) in fiscal year 2011
Fourth Quarter 2012 Highlights:
Revenue for the period was approximately $8.1 million, compared to the
... |
| | | 03/13/13 | Bacterin Announces Earnings Release and Conference Call Date for 2012 Fourth Quarter & Year End Results| BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 13, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it will release its financial
results for the period ended December 31, 2012, after the close of U.S.
financial markets on March 26, 2013.
An accompanying conference call hosted by Guy Cook, Chief Executive
O... |
| | | 02/26/13 | Bacterin International Holdings, Inc. Announces ISO Certification| BELGRADE, Mont.--(BUSINESS WIRE)--Feb. 26, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for
medical applications, today announced that it has achieved ISO
13485:2003 Certification. This certification is an internationally
recognized management system standard developed by the International
Organization for Standardization (ISO).
ISO 13485:20... |
| | | 02/20/13 | Bacterin International Holdings, Inc. Announces Fourth Quarter Revenues| BELGRADE, Mont.--(BUSINESS WIRE)--Feb. 20, 2013--
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and antimicrobial
coatings for medical applications, today announced preliminary revenues
for the fourth quarter and full year ended December 31, 2012.
The company expects to report revenues of approximately $8.1 million in
the fourth quarter of 2012, compared to revenues of... |
| | | 01/22/13 | Bacterin’s OsteoSponge® Product Generates Positive Clinical Results| Clinical Results for Foot and Ankle Fusion Published in “The Journal of Foot & Ankle Surgery”
BELGRADE, Mont.--(BUSINESS WIRE)--Jan. 22, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces that the first clinical results using the OsteoSponge® product for foot and ankle arthrodesis have been published in The Journal of Foot & Ankle Surgery. The arti... |
| | | 01/09/13 | Bacterin International Holdings, Inc. to Present at the OneMed Forum Conference| BELGRADE, Mont.--(BUSINESS WIRE)--Jan. 9, 2013--
Bacterin International Holdings, Inc.(NYSE Amex: BONE), a leader in the
development of revolutionary bone graft material and antimicrobial
coatings for medical applications, today announced it will be presenting
at the 6th Annual OneMed Forum Conference held at the Sir Francis Drake
Hotel in San Francisco, California. John Gandolfo, Bacterin's Chief
Financial Officer, will provide a company presentatio... |
| |
|
